← back to search

Jack L. Arbiser

Emory University · US
Area of research
Rehabilitation · Molecular Biology
Research interest
Research interests include Magnolia and Illicium research, Angiogenesis and VEGF in Cancer, Vascular Tumors and Angiosarcomas, and Melanoma and MAPK Pathways.
h-index
72
citations
17,279
works
401
NIH funding
primary concept
email

Recent publications

Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties
Cells 2023cited by 139position: lastdoi
Early Detection and Prognostic Assessment of Cutaneous Melanoma
JAMA Dermatology 2023cited by 37position: middledoi
Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer
Cell Biology and Toxicology 2022cited by 25position: middledoi
Mitochondrial Metabolism in Melanoma
Cells 2021cited by 36position: lastdoi
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
International Journal of Molecular Sciences 2021cited by 33position: middledoi
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1
Antioxidants and Redox Signaling 2020cited by 39position: middledoi
Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
Molecular Oncology 2020cited by 38position: middledoi
Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1‐ and SIRT3‐mediated autophagy induction
Journal of Cellular and Molecular Medicine 2020cited by 29position: middledoi
Topical Application of Cinnamaldehyde Promotes Faster Healing of Skin Wounds Infected with Pseudomonas aeruginosa
Molecules 2019cited by 53position: middledoi
Propranolol exhibits activity against hemangiomas independent of beta blockade
npj Precision Oncology 2019cited by 43position: lastdoi
Palladium based nanoparticles for the treatment of advanced melanoma
Scientific Reports 2019cited by 29position: lastdoi
Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair
Science 2018cited by 506position: middledoi
Antioxidants: Positive or Negative Actors?
Biomolecules 2018cited by 251position: middledoi
Honokiol is a FOXM1 antagonist
Cell Death and Disease 2018cited by 54position: middledoi
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
Cancer Letters 2018cited by 53position: middledoi
Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer
Biochimica et Biophysica Acta (BBA) - General Subjects 2018cited by 50position: firstdoi
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
Cancer 2018cited by 43position: middledoi
Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
Oncotarget 2017cited by 191position: middledoi
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Cell Metabolism 2017cited by 165position: middledoi
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
Oncogene 2017cited by 94position: middledoi
Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition
Journal of Biological Chemistry 2017cited by 88position: middledoi
Targeting the duality of cancer
npj Precision Oncology 2017cited by 71position: firstdoi
Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone
JAMA Dermatology 2017cited by 64position: middledoi
HMG-CoA synthase 1 is a synthetic lethal partner of BRAFV600E in human cancers
Journal of Biological Chemistry 2017cited by 41position: middledoi
Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol
Molecular Cancer Therapeutics 2017cited by 26position: middledoi
Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis
Scientific Reports 2017cited by 24position: firstdoi
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Oncotarget 2016cited by 108position: middledoi
Inhibition of <i>FoxM1</i> -Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis
Clinical Cancer Research 2016cited by 59position: middledoi
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma<i>in vivo</i>
Oncotarget 2016cited by 39position: lastdoi
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival
Journal of Investigative Dermatology 2016cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Y. Bonner · Karolinska Institutet19 papers (2012–2018)Dipali Sharma · Johns Hopkins University5 papers (2012–2017)Arumugam Nagalingam · Johns Hopkins Medicine5 papers (2012–2017)Neeraj K. Saxena · Integral University5 papers (2012–2017)Justin Elsey · Emory University4 papers (2018–2020)Shikha Rao · Texas Tech University4 papers (2017–2019)Brian P. Pollack · Emory University3 papers (2017–2019)Meei‐Ling Sheu · University of Virginia3 papers (2014–2022) · 3 papers (2014–2022)Mahesh P. Gupta · Butler University3 papers (2015–2017)Dimiter Avtanski · Johns Hopkins Medicine3 papers (2014–2015) · 3 papers (2014–2022)Vinodkumar B. Pillai · University of Chicago2 papers (2015–2017)Palak R. Parekh · Center for Cancer Research2 papers (2015–2015) · 2 papers (2018–2022)Melissa Bonner · Integrated BioTherapeutics (United States)2 papers (2013–2017)Sadhana Samant · University of Chicago2 papers (2015–2017)Taofeek K. Owonikoko · New Mexico Cancer Center2 papers (2014–2020)Christophe E. Redon · Center for Cancer Research2 papers (2015–2015)Maiko Sasaki · Emory University2 papers (2019–2019)